$338 Million is the total value of PURA VIDA INVESTMENTS, LLC's 79 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Sell | SPDR S&P 500 ETF TRput | $11,787,000 | -39.7% | 50,000 | -42.9% | 3.49% | -51.4% |
HOLX | Buy | HOLOGIC INC | $10,744,000 | +24.9% | 252,500 | +17.8% | 3.18% | +0.7% |
BIO | Buy | BIO RAD LABS INCcl a | $10,565,000 | +90.0% | 53,000 | +73.8% | 3.12% | +53.3% |
BAX | Buy | BAXTER INTL INC | $9,335,000 | +40.4% | 180,000 | +20.0% | 2.76% | +13.2% |
BCR | Buy | BARD C R INC | $9,320,000 | +13.7% | 37,500 | +2.7% | 2.76% | -8.3% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $9,078,000 | +10.5% | 365,000 | -3.9% | 2.68% | -10.9% |
EVHC | Sell | ENVISION HEALTHCARE CORP | $8,585,000 | -4.2% | 140,000 | -1.2% | 2.54% | -22.8% |
GMED | Buy | GLOBUS MED INCcl a | $8,461,000 | +70.5% | 285,646 | +42.8% | 2.50% | +37.5% |
EXAS | New | EXACT SCIENCES CORP | $8,267,000 | – | 350,000 | +100.0% | 2.44% | – |
GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $8,248,000 | – | 195,625 | +100.0% | 2.44% | – |
ALXN | New | ALEXION PHARMACEUTICALS INC | $8,184,000 | – | 67,500 | +100.0% | 2.42% | – |
UNH | Sell | UNITEDHEALTH GROUP INC | $7,790,000 | -22.1% | 47,500 | -24.0% | 2.30% | -37.2% |
ABT | New | ABBOTT LABScall | $7,772,000 | – | 175,000 | +100.0% | 2.30% | – |
CNC | New | CENTENE CORP DEL | $7,731,000 | – | 108,491 | +100.0% | 2.29% | – |
ICUI | Buy | ICU MED INC | $7,635,000 | +130.3% | 50,000 | +122.2% | 2.26% | +85.8% |
NXTM | Buy | NXSTAGE MEDICAL INC | $7,378,000 | +9.3% | 275,000 | +6.8% | 2.18% | -11.8% |
PKI | New | PERKINELMER INC | $6,938,000 | – | 119,500 | +100.0% | 2.05% | – |
AGN | Buy | ALLERGAN PLC | $6,899,000 | +390.3% | 28,875 | +331.0% | 2.04% | +295.3% |
ABT | New | ABBOTT LABS | $6,884,000 | – | 155,000 | +100.0% | 2.04% | – |
UHS | New | UNIVERSAL HLTH SVCS INCcl b | $6,845,000 | – | 55,000 | +100.0% | 2.02% | – |
SHPG | New | SHIRE PLCsponsored adr | $6,817,000 | – | 39,125 | +100.0% | 2.02% | – |
XENT | New | INTERSECT ENT INC | $6,653,000 | – | 387,922 | +100.0% | 1.97% | – |
IVC | Buy | INVACARE CORP | $6,248,000 | +114.3% | 525,010 | +135.0% | 1.85% | +72.9% |
FXH | Buy | FIRST TR EXHANGE TRADED FDput | $6,242,000 | +81.6% | 100,000 | +66.7% | 1.85% | +46.5% |
TFX | New | TELEFLEX INC | $5,812,000 | – | 30,000 | +100.0% | 1.72% | – |
AXGT | New | AXOVANT SCIENCES LTD | $5,677,000 | – | 380,000 | +100.0% | 1.68% | – |
AVXS | Buy | AVEXIS INC | $5,522,000 | +120.9% | 72,625 | +38.7% | 1.63% | +78.1% |
CELG | New | CELGENE CORP | $5,475,000 | – | 44,000 | +100.0% | 1.62% | – |
WAT | New | WATERS CORPcall | $5,471,000 | – | 35,000 | +100.0% | 1.62% | – |
WMGI | Buy | WRIGHT MED GROUP N V | $5,446,000 | +69.3% | 175,000 | +25.0% | 1.61% | +36.6% |
LLY | New | LILLY ELI & CO | $5,404,000 | – | 64,250 | +100.0% | 1.60% | – |
SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $5,399,000 | +288.7% | 172,500 | +213.6% | 1.60% | +213.8% |
ABBV | Sell | ABBVIE INC | $5,384,000 | -42.8% | 82,625 | -45.1% | 1.59% | -53.9% |
PEN | Sell | PENUMBRA INC | $5,220,000 | -13.9% | 62,555 | -34.2% | 1.54% | -30.5% |
IWM | Sell | ISHARES TRput | $5,156,000 | -36.3% | 37,500 | -37.5% | 1.52% | -48.6% |
QGEN | New | QIAGEN NV | $4,418,000 | – | 152,500 | +100.0% | 1.31% | – |
MEDP | Buy | MEDPACE HLDGS INC | $4,337,000 | +17.3% | 145,282 | +41.7% | 1.28% | -5.3% |
ABMD | New | ABIOMED INCcall | $4,257,000 | – | 34,000 | +100.0% | 1.26% | – |
SIEN | Buy | SIENTRA INC | $4,250,000 | -0.2% | 504,799 | +1.0% | 1.26% | -19.5% |
PODD | New | INSULET CORP | $4,191,000 | – | 97,256 | +100.0% | 1.24% | – |
KTWO | Sell | K2M GROUP HLDGS INC | $4,162,000 | -14.3% | 202,907 | -16.2% | 1.23% | -30.8% |
ADMS | New | ADAMAS PHARMACEUTICALS INC | $4,156,000 | – | 237,500 | +100.0% | 1.23% | – |
TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $4,007,000 | – | 124,875 | +100.0% | 1.18% | – |
XLV | Sell | SELECT SECTOR SPDR TRput | $3,718,000 | -68.7% | 50,000 | -71.0% | 1.10% | -74.8% |
IMMU | Buy | IMMUNOMEDICS INC | $3,526,000 | +185.5% | 545,000 | +62.0% | 1.04% | +130.2% |
SUPN | New | SUPERNUS PHARMACEUTICALS INCput | $3,287,000 | – | 105,000 | +100.0% | 0.97% | – |
ARAY | Buy | ACCURAY INC | $3,254,000 | +136.8% | 685,100 | +129.3% | 0.96% | +90.9% |
DXCM | New | DEXCOM INC | $2,966,000 | – | 35,000 | +100.0% | 0.88% | – |
NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $2,836,000 | -21.2% | 142,750 | -11.5% | 0.84% | -36.4% |
Buy | NEURODERM LTD | $2,757,000 | +54.9% | 103,850 | +29.5% | 0.82% | +24.8% | |
GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $2,233,000 | – | 60,598 | +100.0% | 0.66% | – |
COLL | New | COLLEGIUM PHARMACEUTICAL INC | $2,012,000 | – | 200,000 | +100.0% | 0.60% | – |
ARRY | Buy | ARRAY BIOPHARMA INC | $1,994,000 | +44.2% | 223,000 | +41.7% | 0.59% | +16.4% |
CLVS | New | CLOVIS ONCOLGY INC | $1,990,000 | – | 31,250 | +100.0% | 0.59% | – |
PCRX | New | PACIRA PHARMACEUTICALS INC | $1,938,000 | – | 42,500 | +100.0% | 0.57% | – |
OTIC | New | OTONOMY INC | $1,684,000 | – | 137,500 | +100.0% | 0.50% | – |
AIMT | New | AIMMUNE THERAPEUTICS INC | $1,521,000 | – | 70,000 | +100.0% | 0.45% | – |
JAZZ | New | JAZZ PHARMACEUTICALS PLC | $1,480,000 | – | 10,200 | +100.0% | 0.44% | – |
ANIP | Buy | ANI PHARMACEUTICALS INC | $1,430,000 | -10.1% | 28,875 | +10.0% | 0.42% | -27.4% |
ARDX | New | AEDELYX INC | $1,297,000 | – | 102,500 | +100.0% | 0.38% | – |
VIVE | Buy | VIVEVE MED INC | $1,229,000 | +52.1% | 194,132 | +23.7% | 0.36% | +22.6% |
ADMP | New | ADAMIS PHARMACEUTICALS CORP | $956,000 | – | 225,000 | +100.0% | 0.28% | – |
FLXN | New | FLEXION THERAPEUTICS INC | $942,000 | – | 35,000 | +100.0% | 0.28% | – |
SGYPQ | New | SYNERGY PHARMACEUTICALS DELcall | $932,000 | – | 200,000 | +100.0% | 0.28% | – |
WMGIZ | Buy | WRIGHT MED GROUP N Vright 03/01/2019 | $899,000 | +16.0% | 587,241 | +0.1% | 0.27% | -6.3% |
ALQA | Buy | ALLIQUA BIOMEDICAL INC | $610,000 | +77.3% | 1,208,026 | +107.2% | 0.18% | +42.9% |
ZYNE | New | ZYNERBA PHARMACEUTICALS INC | $603,000 | – | 30,000 | +100.0% | 0.18% | – |
ELGX | New | ENDOLOGIX INCcall | $547,000 | – | 75,500 | +100.0% | 0.16% | – |
AGRX | AGILE THERAPEUTICS INC | $527,000 | -43.8% | 164,501 | 0.0% | 0.16% | -54.7% | |
New | NEOVASC INC | $520,000 | – | 340,000 | +100.0% | 0.15% | – | |
AXGN | Buy | AXOGEN INC | $519,000 | +133.8% | 49,700 | +101.2% | 0.15% | +88.9% |
STML | New | STEMLINE THERAPEUTICS INC | $513,000 | – | 60,000 | +100.0% | 0.15% | – |
STDY | STEADYMED LTD | $461,000 | +122.7% | 79,434 | 0.0% | 0.14% | +78.9% | |
FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $325,000 | -54.2% | 8,982 | -36.5% | 0.10% | -63.1% |
ARAY | New | ACCURAY INCcall | $238,000 | – | 50,000 | +100.0% | 0.07% | – |
FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $119,000 | -92.2% | 24,100 | -82.4% | 0.04% | -93.7% |
FOMX | New | FOAMIX PHARMACEUTICALS LTDcall | $94,000 | – | 18,900 | +100.0% | 0.03% | – |
HSGX | HISTOGENICS CORP | $23,000 | 0.0% | 13,526 | 0.0% | 0.01% | -12.5% | |
ELGX | Exit | ENDOLOGIX INCput | $0 | – | -4,600 | -100.0% | -0.01% | – |
NXTM | Exit | NXSTAGE MEDICAL INCcall | $0 | – | -10,600 | -100.0% | -0.10% | – |
BVX | Exit | BOVIE MEDICAL CORP | $0 | – | -123,000 | -100.0% | -0.16% | – |
OCRX | Exit | OCERA THERAPEUTICS INC | $0 | – | -258,893 | -100.0% | -0.20% | – |
XENT | Exit | INTERSECT ENT INCcall | $0 | – | -3,000 | -100.0% | -0.24% | – |
ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -0.24% | – |
AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -250,000 | -100.0% | -0.28% | – |
QSII | Exit | QUALITY SYS INCcall | $0 | – | -145,300 | -100.0% | -0.70% | – |
EWA | Exit | ISHAREScall | $0 | – | -100,000 | -100.0% | -0.74% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -47,500 | -100.0% | -1.00% | – |
LPNT | Exit | LIFEPOINT HEALTH INCput | $0 | – | -50,000 | -100.0% | -1.04% | – |
ELGX | Exit | ENDOLOGIX INC | $0 | – | -500,000 | -100.0% | -1.05% | – |
CFMS | Exit | CONFORMIS INC | $0 | – | -419,235 | -100.0% | -1.24% | – |
QSII | Exit | QUALITY SYS INC | $0 | – | -266,617 | -100.0% | -1.28% | – |
GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -32,250 | -100.0% | -1.32% | – |
GKOS | Exit | GLAUKOS CORP | $0 | – | -109,903 | -100.0% | -1.38% | – |
TMO | Exit | THERMO FISHER SCIENTIFIC INCput | $0 | – | -30,000 | -100.0% | -1.55% | – |
BSX | Exit | BOSTON SCIENTIFIC CORPcall | $0 | – | -200,000 | -100.0% | -1.59% | – |
INGN | Exit | INOGEN INCput | $0 | – | -65,000 | -100.0% | -1.60% | – |
ILMN | Exit | ILLUMINA INC | $0 | – | -35,000 | -100.0% | -1.64% | – |
CYNO | Exit | CYNOSURE INCcl a | $0 | – | -100,000 | -100.0% | -1.67% | – |
AET | Exit | AETNA INC NEW | $0 | – | -39,000 | -100.0% | -1.77% | – |
SYK | Exit | STRYKER CORPput | $0 | – | -50,000 | -100.0% | -2.20% | – |
HUM | Exit | HUMANA INC | $0 | – | -33,500 | -100.0% | -2.51% | – |
NUVA | Exit | NUVASIVE INC | $0 | – | -105,000 | -100.0% | -2.59% | – |
IEV | Exit | ISHARES TReurope etf | $0 | – | -186,000 | -100.0% | -2.65% | – |
AGN | Exit | ALLERGAN PLCput | $0 | – | -40,000 | -100.0% | -3.08% | – |
ATHN | Exit | ATHENAHEALTH INC | $0 | – | -95,000 | -100.0% | -3.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.